| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
CH:LONN
Lonza Group Ltd
|
Aug 07, 2026 | BUY |
Strong Buy
+13.9% avg upside
21 analysts
|
$680.00
20.60% Upside
|
· | · |
|
DE:MRK
Merck KGaA
|
Aug 07, 2026 | HOLD |
Buy
-1.7% avg upside
33 analysts
|
$140.00
0.59% Upside
|
· | · |
|
GB:0NZT
UCB SA
|
Aug 03, 2026 | HOLD |
Buy
-0.9% avg upside
19 analysts
|
$260.00
15.21% Upside
|
· | · |
|
IT:REC
Recordati Industria Chimica e Farmaceutica SPA
|
Jul 30, 2026 | HOLD |
Hold
-8.4% avg upside
7 analysts
|
$50.00
5.18% Downside
|
+1.9% | · |
|
DE:BAYN
Bayer
|
Jul 14, 2026 | BUY |
Strong Buy
+8.6% avg upside
30 analysts
|
$60.00
22.87% Upside
|
+3.5% | · |
|
FR:BIM
bioMerieux
|
Jun 23, 2026 | HOLD |
Buy
+34.7% avg upside
12 analysts
|
$80.00
9.47% Upside
|
+6.4% | · |
|
CH:PPGN
PolyPeptide Group AG
|
Jun 16, 2026 | BUY |
Strong Buy
-20.4% avg upside
3 analysts
|
$40.00
9.13% Downside
|
+20.2% | · |
|
CH:BANB
Bachem Holding AG
|
Jun 09, 2026 | HOLD |
Sell
-1.1% avg upside
4 analysts
|
$70.00
4.84% Downside
|
+8.6% | · |
|
DE:SRT3
Sartorius
|
Apr 23, 2026 | BUY |
Buy
+15.7% avg upside
18 analysts
|
$270.00
14.50% Upside
|
+5.7% | · |
|
FR:DIM
Sartorius Stedim Biotech
|
Apr 23, 2026 | BUY |
Strong Buy
+38.2% avg upside
11 analysts
|
$220.00
22.25% Upside
|
+7.4% | · |
|
ES:GRF
Grifols
|
Apr 22, 2026 | BUY |
Buy
+46.3% avg upside
12 analysts
|
$12.50
23.83% Upside
|
+14.0% | · |
|
CH:SDZ
Sandoz Group Ltd
|
Mar 11, 2026 | HOLD |
Buy
-7.0% avg upside
11 analysts
|
$75.00
4.68% Upside
|
+19.6% | · |
|
GB:DIA
Dialight
|
Jan 06, 2026 | SELL |
Strong Sell
1 analyst
|
— | -43.2% | · |
|
BAYRY
Bayer
|
Jan 06, 2026 | BUY |
Buy
+200.0% avg upside
9 analysts
|
— | +28.1% | · |
|
IT:DIA
DiaSorin S.p.A.
|
Jan 06, 2026 | SELL |
Sell
+45.8% avg upside
10 analysts
|
$60.00
18.90% Downside
|
-5.7% | · |
|
GB:0QW0
arGEN X
|
Oct 31, 2025 | BUY |
Strong Buy
-19.1% avg upside
24 analysts
|
$850.00
11.66% Upside
|
· | · |
|
FR:IPN
Ipsen
|
Oct 24, 2025 | HOLD |
Hold
-20.0% avg upside
17 analysts
|
$125.00
19.18% Downside
|
+36.9% | · |
|
ARGX
Argenx Se
|
Apr 28, 2025 | BUY |
Strong Buy
-10.3% avg upside
47 analysts
|
$751.49
12.98% Downside
|
+24.8% | · |
|
GRFS
Grifols SA
|
Jan 04, 2024 | BUY |
Buy
+208.5% avg upside
12 analysts
|
$20.81
162.42% Upside
|
-32.1% | · |
|
ABBV
AbbVie
|
Jan 13, 2022 | BUY |
Strong Buy
-4.0% avg upside
46 analysts
|
— | +19.4% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.